Asia’s largest insect virus formulation base commissioned in China

Recently Jiangxi Xinlong Biotechnology Co., Ltd – a Chinese biological enterprise, commissioned its "1000-ton broad spectrum insect virus formulation production demonstrative project", which becomes Asia’s largest insect virus formulation production base with an annual capacity of above 2000-ton virus formulations.

The Company was launched between Wuhan Institute of Virology, Chinese Academy of Sciences (CAS) and Yichun Xinlong Chemicals Co., Ltd in 2011, located within the Yuanzhou Pharma Industrial Park of Yichun City with a registered capital of Yuan 50 million and a total investment of Yuan 100 million. The Company mainly produces a biopesticide – MbNPV (Mamestra brassicae nuclear polyhedrosis virus) suspension formulation, and achieves production of annually 2000 tons of 2 billion PIB/ml MbNPV suspension formulations (trademark: Kangbang).

Patent certification for MbNPV suspension formulation was attained in 2009, which is a patent product with independent intellectual property; the product registration certificate and pesticide production permit were granted in June 2011, being the first such registration in China.